Effects of Exercise Intensity on Cardiometabolic Parameters of Ovariectomized Obese Mice

Imagem de Miniatura
Arquivos
art_DOS-SANTOS_Effects_of_Exercise_Intensity_on_Cardiometabolic_Parameters_of_2023.PDF (462.93 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
GEORG THIEME VERLAG KG
Autores
DOS-SANTOS, Adriano
COSTA-SANTOS, Nicolas Da
MELLO-SILVA, Fernanda Queiroz de
PEREIRA, Abel de Assis
JESUS, Ney Roberto de
ANGELIS, Katia De
BERNARDES, Nathalia
CAPERUTO, Erico Chagas
Citação
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, v.44, n.8, p.584-591, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The aim of this study was to compare the effects of continuous-moderate vs. high-intensity interval aerobic training on cardiovascular and metabolic parameters in ovariectomized high-fat-fed mice. C57BL/6 female ovariectomized were divided into four groups (n=8): low-fat-fed sedentary (SLF); high-fat-fed sedentary (SHF); high-fat-fed moderate-intensity continuous trained (MICT-HF); and high-fat-fed high-intensity interval aerobic trained (HIIT-HF). The high-fat diet lasted 10 weeks. Ovariectomy was performed in the fourth week. The exercise training was carried out in the last four weeks of protocol. Fasting glycemia, oral glucose tolerance, arterial pressure, baroreflex sensitivity, and cardiovascular autonomic modulation were evaluated. Moderate-intensity continuous training prevented the increase in arterial pressure and promoted a reduction in HR at rest, associated with an improvement in the sympathovagal balance in MICT-HF vs. SHF. The high-intensity interval training reduced blood glucose and glucose intolerance in HIIT-HF vs. SHF and MICT-HF. In addition, it improved sympathovagal balance in HIIT-HF vs. SHF. Moderate-intensity continuous training was more effective in promoting cardiovascular benefits, while high-intensity interval training was more effective in promoting metabolic benefits.
Palavras-chave
menopause, obesity, exercise training, heart rate variability, high-fat diet, high-intensity interval training
URI
https://observatorio.fm.usp.br/handle/OPI/56437
Referências
  1. Abildgaard J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94189-2
  2. Abildgaard J, 2018, J CLIN ENDOCR METAB, V103, P3394, DOI 10.1210/jc.2018-00554
  3. Appiakannan HS, 2020, PHYSIOL BEHAV, V215, DOI 10.1016/j.physbeh.2019.112773
  4. Bernstein D, 2003, PHYSIOL GENOMICS, V13, P217, DOI 10.1152/physiolgenomics.00188.2002
  5. Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909
  6. Abad CCC, 2017, J EXERC REHABIL, V13, P257, DOI 10.12965/jer.1734914.457
  7. Caminiti G, 2019, EUR J PREV CARDIOL, V26, P1028, DOI 10.1177/2047487318819529
  8. Camm AJ, 1996, CIRCULATION, V93, P1043
  9. Campos C, 2008, EXP TOXICOL PATHOL, V60, P329, DOI 10.1016/j.etp.2008.02.005
  10. Carrard J, 2022, SPORTS HEALTH, V14, P665, DOI 10.1177/19417381211044739
  11. Carrick-Ranson G, 2014, J APPL PHYSIOL, V116, P736, DOI 10.1152/japplphysiol.00342.2013
  12. Consitt LA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112636
  13. Craighead DH, 2019, J APPL PHYSIOL, V127, P1427, DOI 10.1152/japplphysiol.00381.2019
  14. De Angelis K, 2004, J APPL PHYSIOL, V96, P2174, DOI 10.1152/japplphysiol.00870.2003
  15. De Angelis K., 2004, REV SOC CARDIOL RIO, V13, P1, DOI 10.1126/science.150.3699.971
  16. Flores LJ, 2010, MENOPAUSE, V17, P712, DOI 10.1097/gme.0b013e3181cdebc9
  17. Flues K, 2010, MATURITAS, V65, P267, DOI 10.1016/j.maturitas.2009.11.007
  18. Gehrmann J, 2000, AM J PHYSIOL-HEART C, V279, pH733, DOI 10.1152/ajpheart.2000.279.2.H733
  19. Goldmeier S, 2014, AM J TRANSL RES, V6, P91
  20. Hariri N, 2010, NUTR RES, V30, P632, DOI 10.1016/j.nutres.2010.09.003
  21. Harriss DJ, 2022, INT J SPORTS MED, V43, P1065, DOI 10.1055/a-1957-2356
  22. Heeren MV, 2009, MATURITAS, V62, P200, DOI 10.1016/j.maturitas.2008.12.011
  23. Irigoyen MC, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0642-9
  24. Kajaia T, 2017, Georgian Med News, P97
  25. Khalafi M, 2022, DIABETES RES CLIN PR, V186, DOI 10.1016/j.diabres.2022.109815
  26. Li G, 2015, PHYSIOL RES, V64, P355, DOI 10.33549/physiolres.932851
  27. Ludgero-Correia A, 2012, NUTRITION, V28, P316, DOI 10.1016/j.nut.2011.07.014
  28. Mandrup CM, 2018, MENOPAUSE, V25, P165, DOI 10.1097/GME.0000000000000981
  29. Marchon C, 2015, CELL PHYSIOL BIOCHEM, V35, P397, DOI 10.1159/000369705
  30. Marcinko K, 2015, MOL METAB, V4, P903, DOI 10.1016/j.molmet.2015.09.006
  31. Masson GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094927
  32. Mercuro G, 2000, AM J CARDIOL, V85, P787, DOI 10.1016/S0002-9149(99)00865-6
  33. Castrillón CIM, 2017, INT J SPORTS MED, V38, P468, DOI 10.1055/s-0042-121898
  34. Moraes-Silva IC, 2010, CLIN EXP PHARMACOL P, V37, pe114, DOI 10.1111/j.1440-1681.2009.05333.x
  35. Peppa M., 2012, ENDOCRINOL METABOL S, VS1, P009
  36. Perrino C, 2011, AM J PHYSIOL-HEART C, V300, pH1983, DOI 10.1152/ajpheart.00784.2010
  37. Pimenta M, 2015, LIFE SCI, V139, P75, DOI 10.1016/j.lfs.2015.08.004
  38. Prior RL, 2008, J AGR FOOD CHEM, V56, P647, DOI 10.1021/jf071993o
  39. Oliveira BRR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197124
  40. REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
  41. Rodrigues B, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-38
  42. Roh J, 2016, CIRC RES, V118, P279, DOI 10.1161/CIRCRESAHA.115.305250
  43. Sá GD, 2017, LIFE SCI, V189, P8, DOI 10.1016/j.lfs.2017.09.012
  44. Sanches IC, 2009, BRAZ J MED BIOL RES, V42, P942, DOI 10.1590/S0100-879X2009001000011
  45. Sanches IC, 2012, MENOPAUSE, V19, P562, DOI 10.1097/gme.0b013e3182358c9c
  46. Souza SBC, 2007, HYPERTENSION, V50, P786, DOI 10.1161/HYPERTENSIONAHA.107.095000
  47. Stork MJ, 2017, HEALTH PSYCHOL REV, V11, P324, DOI 10.1080/17437199.2017.1326011
  48. Stoyell-Conti FF, 2018, J CARDIOVASC ECHOGR, V28, P90, DOI 10.4103/jcecho.jcecho_51_17
  49. Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733
  50. Townsend KL, 2008, ENDOCRINE, V33, P176, DOI 10.1007/s12020-008-9070-1
  51. Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781
  52. Wang NN, 2017, LIFE SCI, V191, P122, DOI 10.1016/j.lfs.2017.08.023
  53. Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576
  54. Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000066, 10.1161/HYP.0000000000000065]
  55. White PAS, 2013, ARQ BRAS ENDOCRINOL, V57, P339, DOI 10.1590/S0004-27302013000500002
  56. Wichi RB, 2009, CLINICS, V64, P253, DOI 10.1590/S1807-59322009000300017
  57. World Health Organization, 2020, OB OV

Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/05
Artigos e Materiais de Revistas Científicas - LIM/59
Artigos e Materiais de Revistas Científicas - LIM/65